JOHNSON & JOHNSON (JNJ) Options Risk Score
Real-time risk analysis for JNJ options traders — updated every 30 minutes.
Data last updated: 2026-10-21
Run a full JNJ options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan JNJ Now — Free →
Is it risky to sell options on JOHNSON & JOHNSON (JNJ) right now?
JOHNSON & JOHNSON (JNJ) currently scores 100 out of 100 for options catalyst risk (HIGH) over a 4-week expiry window. What pushes it there: 12 recent news items, 10 active legal filings and 47 clinical-trial catalysts, all landing inside the 4-week window. Anything at 70 or above counts as HIGH, meaning the premium on JNJ is at least partly compensation for a scheduled event rather than pure time value. It says nothing about direction — only that something is on the calendar.
JNJ shows an IV Rank of 59, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 25%. Read IV Rank alongside the catalyst score: it says how expensive JNJ options are, while the score says whether that price is justified by a scheduled event.
The next JNJ report is not until 2026-10-13, beyond the near-term window.
JOHNSON & JOHNSON (JNJ) current implied volatility and IV Rank
JNJ is trading at an IV Rank of 59 with implied volatility around 25%, alongside a TickerRisk options-risk score of 100/100. That's moderate — options are fairly priced versus the past year, so there's no strong volatility edge in either direction right now; trade the direction, not the vol.
Unsure how to act on this? What IV Rank is worth selling at →
JOHNSON & JOHNSON (JNJ) next earnings date — 2026-10-13
The next report for JNJ is 2026-10-13, which sits beyond the nearest expiry. Nothing scheduled is threatening a near-dated position today, though premium on longer expiries will start to reflect the date as it approaches. JNJ's IV Rank is currently 59.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer